Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone-sulbactam vs cefoperazone-sulbactam in acute respiratory and urinary infections
CTR20132537Phase 3Active
- Sponsor
- United Wehua Pharmaceutical
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ceftriaxone, sulbactam in acute bacterial respiratory infection (ABRI), Acute Bacterial Urinary Tract Infection (UTI), sponsored by United Wehua Pharmaceutical. Started May 2014; status: active.
02
Drugs
ceftriaxonesulbactam
03
Conditions
acute bacterial respiratory infection (ABRI)Acute Bacterial Urinary Tract Infection (UTI)
Beyond the preview
Go deeper on CTR20132537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132537.